MedTrace Logo

Cystoinflation to Prevent Bladder Injury in Cases of Placenta Accreta Spectrum

NCT07050082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2025-09-10

No results posted yet for this study

Summary

Placenta accreta spectrum (PAS) disorders are associated with a high risk of bladder injury .leading to increased morbidity. Cystoinflation, involving controlled retrograde bladder filling, has been proposed as a technique to improve intraoperative visualization and reduce bladder injuries.

Objective To evaluate the efficacy and safety of cystoinflation in preventing bladder injuries in cases of PAS.

Methods This randomized controlled trial included 84 women diagnosed with PAS, allocated equally into cystoinflation and control groups. The cystoinflation group underwent bladder filling with 200 mL saline to facilitate dissection, while the control group did not. Primary outcome measures included the incidence of bladder injury, operative time. Data were analyzed using appropriate statistical tests with significance set at p\<0.05.

Conditions

  • Bladder Injury
  • Accreta, Placenta

Interventions

PROCEDURE

Bladder dissection after filling with 200 cc saline solution

Bladder filling after entering peritoneal cavity, then bladder dissection done to avoid bladder injury

OTHER

Bladder dissection with empty bladder

After entering peritoneal cavity, bladder dissection done with empty bladder

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07050082 on ClinicalTrials.gov